Streamline Health Solutions, Inc. (STRM)
NASDAQ: STRM · Real-Time Price · USD
2.800
-0.289 (-9.36%)
At close: Mar 31, 2025, 4:00 PM
2.837
+0.036 (1.30%)
After-hours: Mar 31, 2025, 5:34 PM EDT
STRM Market Cap
STRM has a market cap or net worth of $11.35 million as of March 31, 2025. Its market cap has decreased by -60.73% in one year.
Market Cap
11.35M
Enterprise Value
24.03M
1-Year Change
-60.73%
Ranking
Category
Stock Price
$2.80
Market Cap Chart
Since December 1, 1998, STRM's market cap has increased from $9.90M to $11.35M, an increase of 14.63%. That is a compound annual growth rate of 0.52%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 28, 2025 | 13.20M | -18.01% |
Dec 31, 2024 | 16.10M | -35.60% |
Dec 29, 2023 | 25.00M | -72.44% |
Dec 30, 2022 | 90.70M | 27.93% |
Dec 31, 2021 | 70.90M | 43.52% |
Dec 31, 2020 | 49.40M | 68.60% |
Dec 31, 2019 | 29.30M | 79.75% |
Dec 31, 2018 | 16.30M | -51.78% |
Dec 29, 2017 | 33.80M | 37.40% |
Dec 30, 2016 | 24.60M | -7.17% |
Dec 31, 2015 | 26.50M | -66.88% |
Dec 31, 2014 | 80.00M | -34.10% |
Dec 31, 2013 | 121.40M | 68.85% |
Dec 31, 2012 | 71.90M | 315.61% |
Dec 30, 2011 | 17.30M | 7.45% |
Dec 31, 2010 | 16.10M | -26.82% |
Dec 31, 2009 | 22.00M | 19.57% |
Dec 31, 2008 | 18.40M | 9.52% |
Dec 31, 2007 | 16.80M | -69.06% |
Dec 29, 2006 | 54.30M | 3.23% |
Dec 30, 2005 | 52.60M | 107.91% |
Dec 31, 2004 | 25.30M | -13.36% |
Dec 31, 2003 | 29.20M | 14.96% |
Dec 31, 2002 | 25.40M | -33.33% |
Dec 31, 2001 | 38.10M | 495.31% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |